Information:
Fel:
ID
33944
Beskrivning
Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01180049
Länk
https://clinicaltrials.gov/show/NCT01180049
Nyckelord
Versioner (1)
- 2019-01-08 2019-01-08 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
8 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Non-Hodgkin's Lymphoma (NHL) NCT01180049
Eligibility Non-Hodgkin's Lymphoma (NHL) NCT01180049
- StudyEvent: Eligibility
Similar models
Eligibility Non-Hodgkin's Lymphoma (NHL) NCT01180049
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Mantle cell lymphoma
Item
have confirmed mantle cell lymphoma diagnosis.
boolean
C0334634 (UMLS CUI [1])
Measurable Disease
Item
have measurable disease.
boolean
C1513041 (UMLS CUI [1])
Prior Therapy Quantity | Stem cell transplant
Item
have received at least 2 prior treatment, which may include stem cell transplant.
boolean
C1514463 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1504389 (UMLS CUI [2])
C1265611 (UMLS CUI [1,2])
C1504389 (UMLS CUI [2])
Organ function | Bone Marrow function
Item
have adequate organ and bone marrow function.
boolean
C0678852 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
Inclusion criteria Additional
Item
there are other criteria--please discuss with your doctor.
boolean
C1512693 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,2])
temsirolimus | mTOR Inhibitor
Item
had any prior treatment with temsirolimus or mtor inhibitor.
boolean
C1707080 (UMLS CUI [1])
C2746052 (UMLS CUI [2])
C2746052 (UMLS CUI [2])
Allogeneic Stem Cell Transplantation Recently | Therapeutic immunosuppression
Item
had allogeneic stem cell transplant within last 6 months and on immunosuppressive therapy.
boolean
C2242529 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0021079 (UMLS CUI [2])
C0332185 (UMLS CUI [1,2])
C0021079 (UMLS CUI [2])
Metastatic malignant neoplasm to brain | Metastatic malignant neoplasm to brain Untreated | CNS metastases | CNS metastases Untreated
Item
has active or untreated brain or central nervous system metastases.
boolean
C0220650 (UMLS CUI [1])
C0220650 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C0686377 (UMLS CUI [3])
C0686377 (UMLS CUI [4,1])
C0332155 (UMLS CUI [4,2])
C0220650 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C0686377 (UMLS CUI [3])
C0686377 (UMLS CUI [4,1])
C0332155 (UMLS CUI [4,2])
Exclusion Criteria Additional
Item
there are other criteria--please discuss with your doctor.
boolean
C0680251 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,2])